Furthermore, consistent with our findings, has been demonstrated an inverse correlation between SWA and the AD tau pathology, as evidenced by PET imaging and CSF tau biomarker levels in the early stages of the disease (Lucey et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.